Leonard JP - Search Results

1

The role of FDG-PET imaging in the management of lymphoma.

Kostakoglu L, Leonard JP, Coleman M, Goldsmith SJ. Kostakoglu L, et al. Among authors: leonard jp. Clin Adv Hematol Oncol. 2004 Feb;2(2):115-21. Clin Adv Hematol Oncol. 2004. PMID: 16163171 Review.

2

Primary non-Hodgkin's lymphoma of bone.

Leonard JP, Coleman M. Leonard JP, et al. Cancer Invest. 1998;16(8):616-7. doi: 10.3109/07357909809032893. Cancer Invest. 1998. PMID: 9844623 No abstract available.

3

Treatment of nonlaparotomized (clinical) stage I and II Hodgkin's disease patients by extended field and splenic irradiation.

Coleman M, Kaufmann T, Nisce LZ, Leonard JP. Coleman M, et al. Among authors: leonard jp. Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1235-8. doi: 10.1016/s0360-3016(99)00511-8. Int J Radiat Oncol Biol Phys. 2000. PMID: 10725636

4

DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL).

Coleman M, Leonard J, Shuster MW, Kaufman TP. Coleman M, et al. Eur J Haematol Suppl. 2001 Jul;64:41-5. Eur J Haematol Suppl. 2001. PMID: 11486401 Clinical Trial.

5

Biology and management of mantle cell lymphoma.

Leonard JP, Schattner EJ, Coleman M. Leonard JP, et al. Curr Opin Oncol. 2001 Sep;13(5):342-7. doi: 10.1097/00001622-200109000-00005. Curr Opin Oncol. 2001. PMID: 11555710 Review.

6

Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.

Kostakoglu L, Leonard JP, Kuji I, Coleman M, Vallabhajosula S, Goldsmith SJ. Kostakoglu L, et al. Among authors: leonard jp. Cancer. 2002 Feb 15;94(4):879-88. Cancer. 2002. PMID: 11920454 Free article. Clinical Trial.

7

PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.

Kostakoglu L, Coleman M, Leonard JP, Kuji I, Zoe H, Goldsmith SJ. Kostakoglu L, et al. Among authors: leonard jp. J Nucl Med. 2002 Aug;43(8):1018-27. J Nucl Med. 2002. PMID: 12163626 Free article.

8

BLT-D (clarithromycin [Biaxin], low-dose thalidomide, and dexamethasone) for the treatment of myeloma and Waldenström's macroglobulinemia.

Coleman M, Leonard J, Lyons L, Pekle K, Nahum K, Pearse R, Niesvizky R, Michaeli J. Coleman M, et al. Leuk Lymphoma. 2002 Sep;43(9):1777-82. doi: 10.1080/1042819021000006303. Leuk Lymphoma. 2002. PMID: 12685831

9

Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone.

Coleman M, Leonard J, Lyons L, Szelenyi H, Niesvizky R. Coleman M, et al. Semin Oncol. 2003 Apr;30(2):270-4. doi: 10.1053/sonc.2003.50044. Semin Oncol. 2003. PMID: 12720151 Clinical Trial.

10

Comparative physical and pharmacologic characteristics of iodine-131 and yttrium-90: implications for radioimmunotherapy for patients with non-Hodgkin's lymphoma.

Leonard JP, Siegel JA, Goldsmith SJ. Leonard JP, et al. Cancer Invest. 2003 Apr;21(2):241-52. doi: 10.1081/cnv-120016421. Cancer Invest. 2003. PMID: 12743990 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

424 results

Search Page